Intrinsic Value of S&P & Nasdaq Contact Us

MannKind Corporation MNKD NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
2/7 Pass
SharesGrow Intrinsic Value
$12.62
+360.6%
Analyst Price Target
$9.00
+228.5%

MannKind Corporation (MNKD) has a consensus analyst rating of Buy, based on 18 analysts covering the stock. Of those, 8 recommend buying, 3 recommend holding, and 7 recommend selling.

The analyst consensus price target for MNKD is $9.00, representing a +228.5% upside from the current price of $2.74. Price targets range from a low of $9.00 to a high of $9.00.

Analyst Consensus — MNKD

Buy
Strong Buy
0
Buy
8
Hold
3
Sell
7
Strong Sell
0
18 analysts
Price Targets
Consensus$9.00
High$9.00
Low$9.00
Median$9.00
Last Month Avg-
Last Quarter Avg-
Last Year Avg$9.25
All-Time Count6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message